Uptake of apoptotic K562 leukaemia cells by immature dendritic cells is greatly facilitated by serum

被引:6
作者
Dalgaard, J [1 ]
Beckstrom, KJ [1 ]
Brinchmann, JE [1 ]
机构
[1] Univ Hosp, Rikshosp, Inst Immunol, N-0027 Oslo, Norway
关键词
D O I
10.1046/j.1365-3083.2003.01332.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DCs) are potent antigen-presenting cells and play an important role in T-cell-mediated immunity. DCs have been shown to induce strong antitumour immune responses both in vitro and in vivo. One way of providing the DCs with all relevant tumour antigens would be to incubate the DCs with material from dead tumour cells. We have examined the uptake of apoptotic and necrotic K562 leukaemia cells by DCs under different culture conditions. Results from coincubation experiments strongly suggested that uptake of apoptotic K562 cells was dependent upon the addition of autologous serum (AS). Under these conditions, 47-79% of all DCs were shown to ingest apoptotic material. AS also seemed to be important for the expression of functionally important markers, most notably HLA class I, CD86, CCR7 and CD83. The vast majority of DCs were shown to ingest necrotic material from K562 cells, with no additional effect of AS. The results suggest that incubation of DCs with apoptotic material for cell therapeutic purposes may best be performed in the presence of AS.
引用
收藏
页码:541 / 549
页数:9
相关论文
共 35 条
[1]   Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs [J].
Albert, ML ;
Sauter, B ;
Bhardwaj, N .
NATURE, 1998, 392 (6671) :86-89
[2]   Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes [J].
Albert, ML ;
Pearce, SFA ;
Francisco, LM ;
Sauter, B ;
Roy, P ;
Silverstein, RL ;
Bhardwaj, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (07) :1359-1368
[3]   Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome c and activation of caspase-3 [J].
Amarante-Mendes, GP ;
Kim, CN ;
Liu, L ;
Huang, Y ;
Perkins, CL ;
Green, DR ;
Bhalla, K .
BLOOD, 1998, 91 (05) :1700-1705
[4]   Efficient ex vivo generation of dendritic cells from CD14+ blood monocytes in the presence of human serum albumin for use in clinical vaccine trials [J].
Araki, H ;
Katayama, N ;
Mitani, H ;
Suzuki, H ;
Nishikawa, H ;
Masuya, M ;
Ikuta, Y ;
Hoshino, N ;
Miyashita, H ;
Nishii, K ;
Minami, N ;
Shiku, H .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (03) :681-689
[5]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[6]   Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo [J].
Boczkowski, D ;
Nair, SK ;
Snyder, D ;
Gilboa, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :465-472
[7]   CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins [J].
Carroll, M ;
OhnoJones, S ;
Tamura, S ;
Buchdunger, E ;
Zimmermann, J ;
Lydon, NB ;
Gilliland, DG ;
Druker, BJ .
BLOOD, 1997, 90 (12) :4947-4952
[8]   The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells [J].
Deininger, MWN ;
Goldman, JM ;
Lydon, N ;
Melo, JV .
BLOOD, 1997, 90 (09) :3691-3698
[9]   Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells [J].
Druker, BJ ;
Tamura, S ;
Buchdunger, E ;
Ohno, S ;
Segal, GM ;
Fanning, S ;
Zimmermann, J ;
Lydon, NB .
NATURE MEDICINE, 1996, 2 (05) :561-566
[10]   CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs [J].
Fang, GF ;
Kim, CN ;
Perkins, CL ;
Ramadevi, N ;
Winton, E ;
Wittmann, S ;
Bhalla, KN .
BLOOD, 2000, 96 (06) :2246-2253